Tamara is a corporate and M&A lawyer focused on complex, strategic transactions, as well as investments. She advises private equity sponsors, venture capital firms, strategic investors and public and private companies on transactions involving sophisticated structures, multiple stakeholders, and significant commercial and regulatory considerations. Her practice also covers corporate finance and securities aspects of complex transactions, including recapitalizations, securities offerings, and bridge financings.
Her work includes acquisitions and divestitures, business combinations, strategic and minority investments, reorganizations, plans of arrangement, joint ventures and other transformative corporate transactions.
She works with clients throughout the transaction lifecycle, from strategy and structuring through diligence, negotiation and execution and collaborates closely with management teams, financial advisors and other external advisors to deliver transactions.
She regularly acts for both investors and companies on cross-border matters and transactions in highly regulated industries, giving her a practical perspective on the interests and dynamics on both sides of a transaction. Tamara’s practice spans a broad range of industries, with experience in the technology and life sciences sectors.
Prior to joining BLG, Tamara practised at another Canadian law firm, where she focused on complex corporate transactions, including mergers and acquisitions, strategic investments and, corporate reorganizations.
Experience
- COSCIENS Biopharma Inc., a publicly traded biopharmaceutical company, in its US$15-million acquisition of Nualtis Corp., a specialty pharmaceutical business focused on proprietary oral thin-film drug delivery technologies.
- COSCIENS Biopharma Inc., a publicly traded biopharmaceutical company, in its US$15-million acquisition of Nualtis Corp., a specialty pharmaceutical business focused on proprietary oral thin-film drug delivery technologies.